57 results
Page 2 of 3
DEFC14C
8cpk2bjp6 1yybwgzl
2 Jun 22
Information statement in contested solicitation
4:24pm
PRER14C
r0szw nkiklamwnaxvev
31 May 22
Preliminary revised information
5:09pm
CORRESP
qewugu u4j2amhlgs
31 May 22
Correspondence with SEC
12:00am
PREC14C
t1ij33v24c jz1f
19 May 22
Preliminary information statement in contested solicitation
5:05pm
10-K/A
pu9 fylp2dx6bq87e
29 Apr 22
Annual report (amended)
4:43pm
DEFC14A
90sqx7hxpnq xathi
29 Apr 22
Proxy in contested solicitation
4:02pm
PRRN14A
yswxfcg
27 Apr 22
Revised preliminary proxy statement filed by non-management
1:13pm
PREC14A
pmetysf8d886
26 Apr 22
Preliminary proxy with contested solicitation
8:48am
PRRN14A
drka1gv tugvul
25 Apr 22
Revised preliminary proxy statement filed by non-management
5:23pm
PREC14A
tn6y8hbzalqt
11 Apr 22
Preliminary proxy with contested solicitation
6:44am
10-K
EX-4.2
59efgke xur
31 Mar 22
Annual report
8:18am
10-K
qj1mczn ngynqxo2s
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
kbixa5ur fo
30 Mar 22
Results of Operations and Financial Condition
7:40am
8-K
EX-99.1
28uhyalmr9cho3
29 Sep 21
Adagio Therapeutics Announces New Data Highlighting the Potential of ADG20 for Treatment and Prevention of COVID-19
4:41pm
10-Q
o8t7f78gw6d8o3x6btx
20 Sep 21
Quarterly report
4:17pm
8-K
EX-3.2
lzg09mraknc 6cjd4kw6
10 Aug 21
Amendments to Articles of Incorporation or Bylaws
5:26pm
8-K
EX-3.1
0kd0o7 55gu
10 Aug 21
Amendments to Articles of Incorporation or Bylaws
5:26pm
424B4
y3a389tbu
6 Aug 21
Prospectus supplement with pricing info
4:54pm